Cyclo Therapeutics, Inc. submits 10-K Annual Report to SEC
Cyclo Therapeutics, Inc. has submitted its 10-K/A Annual Report to the Securities and Exchange Commission, providing an insight into the company’s financial performance and operational highlights for the fiscal year ending on December 31, 2023. The filing includes important exhibits such as EXHIBIT 31.1 and EXHIBIT 31.2, detailing significant aspects of the company’s operations. Additionally, the filing consists of essential documents in various formats, including iXBRL and graphics.
Attachments:
1. FORM 10-K/A
2. EXHIBIT 31.1
3. EXHIBIT 31.2
For more information, you can access the complete submission here.
Company Website: N/A
